Therapeutic Asset Ratings
461 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
MIDAZOLAM
Melanoma
Pfizer
P1
CC
(44)
MIDAZOLAM
Sickle Cell Disease
Pfizer
P1
CC
(44)
Lotiglipron
Diabetes Mellitus
Pfizer
P2
CC
(43)
ARRY-558
Pancreatic Ductal Adenocarcinoma
Pfizer
P1
CC
(43)
Claturafenib
Colorectal Cancer
Pfizer
P1
CC
(43)
Claturafenib
Brain Neoplasm
Pfizer
P1
CC
(43)
Claturafenib
Differentiated Thyroid Carcinoma
Pfizer
P1
CC
(43)
Claturafenib
Malignant Glioma
Pfizer
P1
CC
(43)
Claturafenib
Low Grade Glioma
Pfizer
P1
CC
(43)
Claturafenib
Cancer
Pfizer
P1
CC
(43)
FULVESTRANT
Endometrial Disorder
Pfizer
P1
CC
(43)
IMMUNOGLOBULIN G1, ANTI-(HUMAN TISSUE FACTOR PATHWAY INHIBITOR) (HUMAN MONOCLONAL PF-06741086 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL PF-06741086 .LAMBDA.-CHAIN, DIMER
Severe Hemophilia A
Pfizer
P1
CC
(43)
Osivelotor
Kidney Failure
Pfizer
P1
CC
(43)
pf-07224826
Endometrial Disorder
Pfizer
P1
CC
(43)
pf-07224826
Liposarcoma
Pfizer
P1
CC
(43)
pf-07263689
Hepatocellular Carcinoma
Pfizer
P1
CC
(43)
pf-07263689
Non-Small Cell Lung Carcinoma
Pfizer
P1
CC
(43)
pf-07263689
Renal Cell Carcinoma
Pfizer
P1
CC
(43)
pf-07265028
Gastroesophageal Junction Adenocarcinoma
Pfizer
P1
CC
(43)
pf-07265028
Head And Neck Squamous Cell Carcinoma
Pfizer
P1
CC
(43)
pf-07799544
Brain Neoplasm
Pfizer
P1
CC
(43)
pf-07799544
Differentiated Thyroid Carcinoma
Pfizer
P1
CC
(43)
pf-07799544
Malignant Glioma
Pfizer
P1
CC
(43)
pf-07799544
Low Grade Glioma
Pfizer
P1
CC
(43)
pf-07799544
Cancer
Pfizer
P1
CC
(43)
Showing 276 to 300 of 461 assets
Previous
Page 12 of 19
Next
